Monjazeb, A. M., Ayala, D., Jensen, C., Case, L. D., Bourland, J. D., Ellis, T. L., … Shaw, E. G. (2012). A Phase I Dose Escalation Study of Hypofractionated IMRT Field-in-Field Boost for Newly Diagnosed Glioblastoma Multiforme. International Journal of Radiation Oncology*Biology*Physics, 82(2), 743–748. https://doi.org/10.1016/j.ijrobp.2010.10.018

Monjazeb, Arta M., Deandra Ayala, Courtney Jensen, L Douglas Case, J Daniel Bourland, Thomas L. Ellis, Kevin P. McMullen, et al. “A Phase I Dose Escalation Study of Hypofractionated IMRT Field-in-Field Boost for Newly Diagnosed Glioblastoma Multiforme.” International Journal of Radiation Oncology*Biology*Physics 82, no. 2 (February 2012): 743–48. https://doi.org/10.1016/j.ijrobp.2010.10.018.

Monjazeb AM, Ayala D, Jensen C, Case LD, Bourland JD, Ellis TL, et al. A Phase I Dose Escalation Study of Hypofractionated IMRT Field-in-Field Boost for Newly Diagnosed Glioblastoma Multiforme. International Journal of Radiation Oncology*Biology*Physics. 2012 Feb;82(2):743–8.

Monjazeb, Arta M., et al. “A Phase I Dose Escalation Study of Hypofractionated IMRT Field-in-Field Boost for Newly Diagnosed Glioblastoma Multiforme.” International Journal of Radiation Oncology*Biology*Physics, vol. 82, no. 2, Elsevier BV, Feb. 2012, pp. 743–48. Crossref, doi:10.1016/j.ijrobp.2010.10.018.

Monjazeb AM, Ayala D, Jensen C, Case LD, Bourland JD, Ellis TL, McMullen KP, Chan MD, Tatter SB, Lesser GJ, Shaw EG. A Phase I Dose Escalation Study of Hypofractionated IMRT Field-in-Field Boost for Newly Diagnosed Glioblastoma Multiforme. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2012 Feb;82(2):743–748.